Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test
- 1 November 1988
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 26 (11) , 2415-2420
- https://doi.org/10.1128/jcm.26.11.2415-2420.1988
Abstract
Four separate laboratories performed antimicrobial susceptibility tests with 40 Haemophilus influenzae isolates, each tested in triplicate. Erythromycin and a new macrolide, clarithromycin (A-56268; TE-031), were tested by the disk diffusion method, by the agar dilution procedure in two different media, and by broth microdilution tests in four different media. Erythromycin MICs for 90% of the strains were 16 .mu.g/ml in Mueller-Hinton broth with 3% lysed horse blood and NAD, 4.0 .mu.g/ml in hemophilus test medium, and 2.0 .mu.g/ml in supplemented Schaedler broth or in the fastidious broth medium from Beckman Instruments, Inc. Clarithromycin MICs were generally 1 doubling dilution greater than erythromycin MICs in each of the media. Erythromycin disk tests corresponded best with MICs determined in the fastidious broth medium. In that same medium, clarithromycin MICs were about 1 doubling dilution greater than what would be expected from the results of disk tests. Because there were fever growth failures, hemophilus test medium is recommended for microdilution tests with H. influenzae. Incubation of all tests for a full 24-h without an increased CO2 atmosphere was needed to achieve maximal precision of the tests. Interlaboratory and intralaboratory reproducibility of all tests was satisfactory.This publication has 12 references indexed in Scilit:
- Improved medium for antimicrobial susceptibility testing of Haemophilus influenzaeJournal of Clinical Microbiology, 1987
- Comparative in vitro activity of A-56268 against respiratory tract pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia modelAntimicrobial Agents and Chemotherapy, 1987
- Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031)Journal of Clinical Microbiology, 1987
- In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1987
- Disk diffusion and disk elution tests with A-56268 and erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycinAntimicrobial Agents and Chemotherapy, 1987
- Antibiotic interaction of amoxycillin and clavulanic acid against 132 β-lactamase positive Haemophilus isolates: a comparison with some other oral agentsJournal of Antimicrobial Chemotherapy, 1987
- In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolideAntimicrobial Agents and Chemotherapy, 1986
- Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965)Journal of Clinical Microbiology, 1986